Skip to main content
OpenTrials
Completed

NCT Number: NCT04296227

Comparison of Non-Invasive Blood Pressure Methods

The primary objective of the study is to demonstrate the accuracy in healthy adults with Vital USA Device by comparison to a non-invasive (auscultatory) reference sphygmomanometer.

The procedure, data collection methods and data analysis that are outlined in the protocol follow the standard: International Standards Organization (ISO) 81060-2:2018 Non-invasive Sphygmomanometers - Part 2: Clinical validation of automated measurement type.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Clinimark Laboratory Services

Louisville, Colorado, 80027, United States

About this study

This study will include up to 100 adults ≥ 18 years of age. The final subject database will contain no fewer than 85 subjects with a minimum of 255 paired observations. At least 90% of the subjects will contribute 3 paired observations, if necessary the balance of the data will be added from additional subjects.

An interim analysis will be conducted at the end of Part 1 data collection and will consist of simple statistics that will compare the test device tot he reference cuff non-invasive (auscultatory) reference sphygmomanometer.

Part 2 data collection will be conducted after Part 1 data collection interim report is reviewed and additional data collection is approved by the client. It will test an additional 55 subjects (plus extra subjects as replacements if necessary).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects must be able to provide an informed consent or have legally authorized representative consent to participate.
  • Subject must be willing and able to comply with the study procedures.
  • Subject must be ≥ 18
  • Subject or legally authorized representative must be able to read or write in English.
  • Subjects with a finger circumference < 8.3 cm.in the range of 10-25 mm
  • At least 30% of subjects shall be male and at least 30% of subjects shall be female

Exclusion criteria

  • Lack of Informed consent.
  • Subjects with deformities or abnormalities that may prevent proper application of the device under test.
  • Subject is evaluated by the investigator or clinician and found to be medically unsuitable for participation in this study.
  • Subjects with known heart dysrhythmias
  • Subjects with compromised circulation or peripheral vascular disease.
  • Subjects with clotting disorders or taking prescribed blood thinners.
  • Subjects that cannot tolerate sitting for up to 1 hour.
  • Subject with a blood pressure demographic that has already been filled

Treatment and study plan

The Vital Detect blood pressure monitor

Device

The end goal is to provide Non-invasive Blood Pressure (NIBP) accuracy data to support validation of the Vital Detect blood pressure monitor.

Primary outcomes

  1. Validate Non-invasive Blood Pressure Measurement Accuracy for the Vital Detect Blood Pressure Monitor.

    Time frame: 1 Hour

    The primary objective of this study is to provide a validation for non-invasive blood pressure measurement accuracy for the Vital Detect blood pressure monitor when compared to the Reference Sphygmomanometer. Data taken was based on dual observers (Criterion 1(C1), Criterion 2 (C2) for both Systolic and Diastolic determinations. Since the same arm sequential method was used, data for a given subject were averaged to create the reference blood pressure determination against the acceptance criteria. The device under test (DUT) passed or failed the determination based on the mean error and standard deviation of the determination. The acceptance criteria:

    Criterion 1:

    Mean Error Standard Deviation (Systolic / Diastolic) (Systolic / Diastolic) </= 5.0 mmHg </= 8.0 mmHg

    Criterion 2:

    Standard Deviation (Systolic) (Diastolic) </= 5.33 mmHg </= 6.09 mmHg

Sponsors and collaborators

Lead sponsor

Vital USA, Inc.

Industry

Collaborators

  • Clinimark, LLC

Registry information

Official study title

Multiparameter Monitor Non-Invasive Blood Pressure Validation Study

Acronym: NIBP

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Mar 5, 2020
Registry last updated
May 13, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.